ANIX

Anixa Biosciences INC

-$4.4M

Net Activity

Institutions Holding

61

Popularity Rank

#5533

Avg Weight

0.00%

Total Value

$13.3M

Ownership Trend

61 institutions currently hold ANIX, with 22 net buyers and 26 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

26

Net Buying Institutions

22

Key Holders

View all 61 holding institutions

Quarterly Activity

Recent Activity

+$4.6M

Total Buy Value

$6.1M

Total Sell Value

New buy7
Trim10
Add15
Sold out16

22

Net Buyers

26

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ANIXA BIOSCIENCES INC (ANIX)?
Major stakeholders currently include Vanguard Capital Management LLC ($3.4M), Laird Norton Wetherby Trust Company, LLC ($1.5M), UBS Group AG ($1.4M). Based on the latest 13F filings, there are a total of 61 tracked investment funds and institutions maintaining positions in ANIX.
What is the overall institutional sentiment toward ANIX recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $4.4M, driven by 22 managers accumulating shares while 26 reduced their exposure.
Which institutions have been selling or reducing their ANIX positions?
In the latest period, 10 funds trimmed their holdings, and 16 managers completely exited their positions. The aggregate reported sell value was $6.1M.
Are there any notable investors adding ANIX to their portfolios?
Yes, buying activity remains notable. 7 institutions opened new positions in {ticker}, and 15 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.6M.

Related Stocks